You can make research and trials easier with our Trials Delivery Framework. Find out more zurl.co/uJ321

Our READ-OUT study is helping to shape how the NHS can use blood biomarkers to increase the number of people getting an accurate dementia diagnosis. It's part of the Blood Biomarker Challenge, a multi-million pound initiative led by Alzheimer’s Society, Alzheimer’s Research UK.

DPUK's data portal has multimodal data available to researchers:
👩‍👩‍👧‍👦 >107 datasets with epidemiologic and clinical data (n>3.5m),
🧠>300,000 neuroimaging scans across 20 cohorts, and
⛓️genomic data for >140,000 participants from 16 cohorts.
zurl.co/HztoH

DPUK's Trials Delivery Framework can reduce screen failures causing trial delays, rising costs and frustration for patients.

Find out about our Feasibility Tool, tailored to identify the most relevant and appropriate people for your research.
zurl.co/TQhgt

Great Minds recruits highly characterised volunteers willing to participate in experimental medicine and clinical trials. It's a register that continues to grow with around 13,500 people available as candidates for research. #trialsdelivery #dementia
zurl.co/5ddpT

With 107 multimodal datasets and access to records of 3.5m people, all the analytical tools you need plus your own working space, there are plenty of reasons to make use of our Data Portal.
Best of all, it is FREE to use.
Find out more: zurl.co/yzXsk

DPUK's network of 80+ Trials Delivery sites across the UK is available for
📊Collecting patient data
💉Plasma biomarkers & digital cognitive assessments
📌Study & Trial centres
👩‍👩‍👧‍👦 Recruiting to registers, studies & trials.
Find out more: zurl.co/YC8jP

Great to have such good converations about DPUK at #ADPD2026. As Prof Sarah Bauermeister commented: "The high level of interest in our Data Portal and Trials Delivery Network showed how essential they are for human-based and translational research." zurl.co/iMiXv

BrainWaves Living Well 2026 - BrainWaves BrainWaves Living Well 2026 is a unique scientific and educational conference that brings together researchers, educators, and partners.

Please share with your colleagues with research interests in adolescence or teenage mental health and wellbeing. This is a fascinating conference to attend. #teens #adolescent #wellbeing #schools #education mentalhealth #depression #anxiety #learning
zurl.co/ucFwb

We’re excited to be at Booth 04 at #ADPD2026 with the Alzheimer's Disease Data Initiative showcasing interopability & how @dementiasplatform.bsky.social (Dementias Platform UK) helps accelerate #ADPD research. It is the place to find out about our free-to-use DPUK Data Portal. zurl.co/42Cs7

We're looking forward to seeing you at #ADPD2026 in Copenhagen this week. Find us at the @AlzData (ADDI) stand. Come and find out about our free-to-access Data Portal and UK Trials Delivery network. #dementia #brain #cognition #neurodegeneration

Trial using blood tests to diagnose dementia comes to the North East A groundbreaking trial exploring the potential of blood tests to diagnose dementia is now underway in Tees, Esk and Wear Valleys NHS Foundation Trust.

It's great to have Tees, Esk and Wear Valleys NHS Foundation Trust starting to recruit participants in our #READ-OUT study - helping to bring effective early diagnosis of dementia to more people in the NHS 🔗READ MORE - zurl.co/QJevL

Have you used the Data Portal at Dementias Platform UK yet?
It's FREE-TO ACCESS all 107 datasets.

Take a look yourself and see how it can help you.
#translationalmedicine #healthdata #dementia #cognition #neuroimaging
zurl.co/NVOPb

We're busy meeting lots of researchers at #FORACURE ARUK Research conference in Manchester. Grab a coffee and come for a chat to find out how you can use our Data Portal and Trials Delivery Network for FREE.

There is plenty to talk about at #ARUK2026. Please call round to say "hello".

Blood Biomarkers can widen access to #dementia diagnosis in less well-resourced settings where gold-standard PET and lumber puncture tests are hard to access. They are scalable and could be used in low- and middle-income countries #LMICs to extend accurate diagnosis. zurl.co/dTu4m

DPUK’s focus: building “complex knowledge” — integrating imaging, genomics, biomarkers, trials and AI etc., within shared research architectures. Connecting these disciplines is a force multiplier for #dementia discovery. #DementiaResearch #TranslationalScience
zurl.co/oKkaN

Targeting toxic protein chains could slow neurodegenerative disease New research reveals that repetitive strings of the amino acid serine can kill brain cells and accelerate the formation of toxic tau tangles associated with Alzheimer’s disease.

Targeting toxic protein chains could slow neurodegenerative disease

flip.it/zefWMZ

DPUK is advancing cross-platform data federation with international partners, enabling secure analysis without data transfer. A practical solution to global collaboration while preserving governance standards. #DataFederation #OpenScience

zurl.co/mbRTe

DPUK's Trials Delivery Framework is the largest dementia-focused network in the UK, with participant registers and a UK-wide clinical network. Read more about the expanding reach and growing use of our resources in our latest Annual Report.
Download your copy now: zurl.co/TYthy

"Our progress has relied on developing a high trust, pre-competitive environment in which collaboration thrives." (Prof John Gallacher)
Read more about our science, resources & activities.
DPUK Annual Report 2025: Embracing Complexity.
zurl.co/uMVSw
#dementia #MCI #neurodegeneration

Download our 2025 Annual Report: Embracing Complexity
Data Portal, Trials Delivery, Experimental Medicine, Translational Research
zurl.co/9K8sY

#dementia #ageing #cognition #brain #neurdegeneration #healthdata #mnd #MRC #AI #imaging #genomics #biomarkers

The top tips dementia experts use to protect themselves Gill Livingston, a professor of psychiatry of older people at University College London says: 'Alcohol is a toxin that can affect memory and raise your dementia risk.'

Here's a really useful guide to dementia (Daily Mail & @alzheimerssoc.bsky.social)
Read Prof Vanessa Raymont's (DPUK) excellent guide to early signs of dementia which are so important to getting an early diagnosis and managing the disease.
zurl.co/BWukH

On World Lewy Body Dementia Day, we are highlighting 2 neuroimmunology studies from our team at the University of Cambridge: IMPRINT is looking at the onset of the disease; and IMPACT, investigating the role of brain inflammation in DLB with PET scanning. zurl.co/EhBs5

The last year saw record growth in applications to access data on our portal.

📈 169 applications from 19 countries.
📥 Over 550 individual data access requests
🙋🏽 Assisting 1,300 portal users

Find out what resources are available: zurl.co/w4846

At least 479 publications cite DPUK or have used our resources.
These are only the papers we know about.
Take a look at the research publication page on our website and scroll or search the list: zurl.co/Ytg9g

Another exciting blood biomarker study Bio-Hermes-002...Welcomed by Prof Vanessa Raymont DPUK's READ-OUT study/Blood Biomarker Challenge: “It's an opportunity for the comparison of very accessible markers with more validated markers such as PET imaging."
zurl.co/FvTvg

Help DPUK's #LACI-Cog study? It's testing 2 treatments for #vascular #cognitiveimpairment & #dementia in people with memory problems caused by damaged blood vessels in the #brain. Access the survey at #POPPED, the PPIE site zurl.co/17YET. Anyone can complete it.

We are looking for people to take a short survey online to find the best approach to supporting people taking an APOE4 test. You don't need to have a diagnosis. You could be a carer or work in research or the NHS. Read about the survey here: zurl.co/C9wCH

📚 340+ publications enabled or cited DPUK in the last 5 years
Our reach is broad. Our impact is real.
From data infrastructure to research collaborations - we're supporting discoveries that matter.
#DementiaResearch #ResearchImpact #DPUK